Application of active substances contained GIDROKSISTILBEN for the prevention and / or treatment of diseases

摘要

1.the application of u0433u0438u0434u0440u043eu043au0441u0438u0441u0442u0438u043bu044cu0431u0435u043du0441u043eu0434u0435u0440u0436u0430u0449u0435u0439 combinations of active substances and active agents u043au043eu043cu0431u0438u043du0430u0446u0438u00a0 essentially contains u0440u0430u043fu043eu043du0442u0438u0446u0438u043d and u0434u0435u0437u043eu043au0441u0438u0440u0430u043fu043eu043du0442u0438u0446u0438u043d in ma u0441u0441u043eu0432u043eu043c ratio from about 10: 1 to 1: 10 or u0441u0442u0435u0440u0435u043eu0438u0437u043eu043cu0435u0440u043du044bu0435 form respectively in the form of its salts or u0444u0435u043du043eu043bu044cu043du043eu0439 form or their derivatives or complex esters u0441u0442u044bu0445 ethers.u0434u043bu00a0 u043fu043eu043bu0443u0447u0435u043du0438u00a0 means u043bu0435u0447u0435u043du0438u00a0 prostate cancer and / or of the lower urinary tract.;2. application 1, and u043au043eu043cu0431u0438u043du0430u0446u0438u00a0 active substances is a general u0433u0438u0434u0440u043eu043au0441u0438u0441u0442u0438u043bu044cu0431u0435u043du0430 content less than 90 mas.%; and / or (b) the total content of u0433u043bu0438u043au043eu0437u0438u0434u043du044bu0445 u043fu0440u0435u0434u0448u0435u0441u0442u0432 u0435u043du043du0438u043au043eu0432 u0440u0435u0441u0432u0435u0440u0430u0442u0440u043eu043bu0430 and u043fu0438u0446u0435u0430u0442u0430u043du043du043eu043bu0430 more than 76 mas.%, and / or (c) of less than 5 u0430u0433u043bu0438u043au043eu043du0430 mas.%; and / or (d) the content of the u0430u043du0442u0440u0430u0445u0438u043du043eu043du0430 and / or u0430u043du0442u0440u0430u0445u0438u043du043eu0438u0434u043eu0432 less than 0.5 mas .%.;3. application of 1, with the components u0433u0438u0434u0440u043eu043au0441u0438u0441u0442u0438u043bu044cu0431u0435u043du0430 combinations of active substances or chemically synthesizing a u0432u044bu0434u0435u043bu00a0u044eu0442 from plants.;4. application 1, and u043au043eu043cu0431u0438u043du0430u0446u0438u00a0 active substances essentially contains u0440u0430u043fu043eu043du0442u0438u0446u0438u043d and u0434u0435u0437u043eu043au0441u0438u0440u0430u043fu043eu043du0442u0438u0446u0438u043d.;5. application 1, and u043au043eu043cu0431u0438u043du0430u0446u0438u00a0 active substances contained u0440u0430u043fu043eu043du0442u0438u0446u0438u043d, u0434u0435u0437u043eu043au0441u0438u0440u0430u043fu043eu043du0442u0438u0446u0438u043d and u0440u0430u043fu043eu043du0442u0438u0433u0435u043du0438u043d and / or u0434u0435u0437u043eu043au0441u0438u0440u0430u043fu043eu043du0442u0438u0433u0435u043du0438u043d.;6. application 1, and u043au043eu043cu0431u0438u043du0430u0446u0438u00a0 active substances essentially free from u0430u0433u043bu0438u043au043eu043du043eu0432u044bu0445 derivatives u0440u0430u043fu043eu043du0442u0438u0446u0438u043du0430 and u0434u0435u0437u043eu043au0441u0438u0440u0430u043fu043eu043du0442u0438u0446u0438u043du0430.;7. the application of one of the u043fu043f.1 - 6 and u043au043eu043cu0431u0438u043du0430u0446u0438u00a0 active substances essentially consists of approximately;60 - 70% u0440u0430u043fu043eu043du0442u0438u0446u0438u043du0430 mas.;30 - 40% u0434u0435u0437u043eu043au0441u0438u0440u0430u043fu043eu043du0442u0438u0446u0438u043du0430 mas.;0 - 2% u0442u0440u0430u043du0441u0440u0430u043fu043eu043du0442u0438u0433u0435u043du0438u043du0430 mas.;0 - 2 mas. u0434u0435u0437u043eu043au0441u0438u0440u0430u043fu043eu043du0442u0438u0433u0435u043du0438u043du0430.;8. the application of one of the u043fu043f.1 - 6, with the active substance or a combination of active substances derived from plants of the family Rheum spp., Astragalus spp., Cassia spp.u0438u043bu0438 picea spp.;9. the application of one of the u043fu043f.1 - 6, with the active substance or a combination of active substances derived from roots and / or other parts of plants Rheum rhaponticum.;10. the application of one of the u043fu043f.1 - 6, in combination with at least one other active substance suitable u0434u043bu00a0 prevention and / or u043bu0435u0447u0435u043du0438u00a0 one of diseases, oprah times in 1, and u043eu0442u043bu0438u0447u0430u044eu0449u0438u043cu0441u00a0 from compounds as defined in paragraph 1.;11. the application of one of the u043fu043f.1 - 6, with a choice of chemical synthetic methods of biotechnology, plant and homeopathic u043bu0435u043au0430u0440u0441u0442 public funds, other compositions of medicinal plants, food supplements and dietary products u043fu0438u0442u0430u043du0438u00a0.;12. the use of combinations of active substances on one of the u043fu043f.1 - 6 u0434u043bu00a0 u043fu043eu043du0438u0436u0435u043du0438u00a0 u0443u0440u043eu0432u043du00a0 il - 6 in serum and in vitro or in vivo or u0434u043bu00a0 selective u0430u043au0442u0438u0432u0438u0440u043eu0432u0430u043du0438u00a0 er in vitro or in vivo.